FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2947367043> ?p ?o ?g. }

• W2947367043 endingPage "523" @default.
• W2947367043 startingPage "523" @default.
• W2947367043 abstract "IBD98-M is a delayed-release formulation of mesalamine (mesalazine) and SH with a potential therapeutic role in ulcerative colitis (UC). A total of 51 patients with a modified Ulcerative Colitis Disease Activity Index (UCDAI) score of ≥4 and ≤10, and a modified UCDAI endoscopy subscore ≥1 were randomized for 6 weeks of double-blind treatment with IBD98 0.8 g/day or IBD 1.2 g/day or placebo. The efficacy and safety of IBD98-M in mild to moderate active UC were primarily evaluated. At week 6, 1 (5.9%), 2 (12.5%), and 2 (11.1%) patients receiving IBD98-M 0.8 g, IBD98-M 1.2 g, and placebo, respectively, (p > 0.999) achieved clinical remission. Higher clinical response was seen in IBD98-M 1.2 g (31.3%) versus placebo (16.7%) and endoscopic improvement in IBD98-M 0.8 g (29.4%) versus placebo (22.2%) was seen. Fecal calprotectin levels were reduced in IBD98-M groups versus placebo (p > 0.05). IBD98-M patients achieved significant improvement in physical health summary score component of the SF-36 (p = 0.01 and p = 0.03 respectively) compared to placebo. IBD98-M did not meet the primary end point but had higher clinical response (1.2 g/day) and endoscopic improvement (0.8 g/day) compared to placebo. The safety result shown that IBD98-M treatment was safe and well tolerated in this patient population. No new safety signals or unexpected safety findings were observed during the study. Further trials with different stratification and longer follow-up may be needed to evaluate the efficacy." @default.
• W2947367043 created "2019-06-07" @default.
• W2947367043 creator A5014483659 @default.
• W2947367043 creator A5035662512 @default.
• W2947367043 creator A5040818753 @default.
• W2947367043 creator A5046111364 @default.
• W2947367043 creator A5066649201 @default.
• W2947367043 creator A5086927377 @default.
• W2947367043 creator A5088008401 @default.
• W2947367043 date "2019-05-30" @default.
• W2947367043 modified "2023-10-16" @default.
• W2947367043 title "A Phase 2a, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis" @default.
• W2947367043 cites W1959828319 @default.
• W2947367043 cites W2015151182 @default.
• W2947367043 cites W2022148879 @default.
• W2947367043 cites W2025969146 @default.
• W2947367043 cites W2029409133 @default.
• W2947367043 cites W2044860512 @default.
• W2947367043 cites W2045781806 @default.
• W2947367043 cites W2074809218 @default.
• W2947367043 cites W2097042204 @default.
• W2947367043 cites W2108668442 @default.
• W2947367043 cites W2124462125 @default.
• W2947367043 cites W2132526550 @default.
• W2947367043 cites W2136669583 @default.
• W2947367043 cites W2138119117 @default.
• W2947367043 cites W2151335404 @default.
• W2947367043 cites W2156272127 @default.
• W2947367043 cites W2583633660 @default.
• W2947367043 cites W2610345163 @default.
• W2947367043 cites W2897056814 @default.
• W2947367043 cites W4230633180 @default.
• W2947367043 cites W4231456852 @default.
• W2947367043 cites W4238477827 @default.
• W2947367043 cites W4246198023 @default.
• W2947367043 cites W4292806894 @default.
• W2947367043 doi "https://doi.org/10.3390/cells8060523" @default.
• W2947367043 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6627752" @default.
• W2947367043 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31151306" @default.
• W2947367043 hasPublicationYear "2019" @default.
• W2947367043 type Work @default.
• W2947367043 sameAs 2947367043 @default.
• W2947367043 citedByCount "9" @default.
• W2947367043 countsByYear W29473670432019 @default.
• W2947367043 countsByYear W29473670432020 @default.
• W2947367043 countsByYear W29473670432021 @default.
• W2947367043 countsByYear W29473670432022 @default.
• W2947367043 countsByYear W29473670432023 @default.
• W2947367043 crossrefType "journal-article" @default.
• W2947367043 hasAuthorship W2947367043A5014483659 @default.
• W2947367043 hasAuthorship W2947367043A5035662512 @default.
• W2947367043 hasAuthorship W2947367043A5040818753 @default.
• W2947367043 hasAuthorship W2947367043A5046111364 @default.
• W2947367043 hasAuthorship W2947367043A5066649201 @default.
• W2947367043 hasAuthorship W2947367043A5086927377 @default.
• W2947367043 hasAuthorship W2947367043A5088008401 @default.
• W2947367043 hasBestOaLocation W29473670431 @default.
• W2947367043 hasConcept C126322002 @default.
• W2947367043 hasConcept C141071460 @default.
• W2947367043 hasConcept C142724271 @default.
• W2947367043 hasConcept C168563851 @default.
• W2947367043 hasConcept C197934379 @default.
• W2947367043 hasConcept C203092338 @default.
• W2947367043 hasConcept C204787440 @default.
• W2947367043 hasConcept C27081682 @default.
• W2947367043 hasConcept C2778260677 @default.
• W2947367043 hasConcept C2778292693 @default.
• W2947367043 hasConcept C2779134260 @default.
• W2947367043 hasConcept C2779174533 @default.
• W2947367043 hasConcept C2780479503 @default.
• W2947367043 hasConcept C2908647359 @default.
• W2947367043 hasConcept C535046627 @default.
• W2947367043 hasConcept C71924100 @default.
• W2947367043 hasConcept C90924648 @default.
• W2947367043 hasConcept C99454951 @default.
• W2947367043 hasConceptScore W2947367043C126322002 @default.
• W2947367043 hasConceptScore W2947367043C141071460 @default.
• W2947367043 hasConceptScore W2947367043C142724271 @default.
• W2947367043 hasConceptScore W2947367043C168563851 @default.
• W2947367043 hasConceptScore W2947367043C197934379 @default.
• W2947367043 hasConceptScore W2947367043C203092338 @default.
• W2947367043 hasConceptScore W2947367043C204787440 @default.
• W2947367043 hasConceptScore W2947367043C27081682 @default.
• W2947367043 hasConceptScore W2947367043C2778260677 @default.
• W2947367043 hasConceptScore W2947367043C2778292693 @default.
• W2947367043 hasConceptScore W2947367043C2779134260 @default.
• W2947367043 hasConceptScore W2947367043C2779174533 @default.
• W2947367043 hasConceptScore W2947367043C2780479503 @default.
• W2947367043 hasConceptScore W2947367043C2908647359 @default.
• W2947367043 hasConceptScore W2947367043C535046627 @default.
• W2947367043 hasConceptScore W2947367043C71924100 @default.
• W2947367043 hasConceptScore W2947367043C90924648 @default.
• W2947367043 hasConceptScore W2947367043C99454951 @default.
• W2947367043 hasIssue "6" @default.
• W2947367043 hasLocation W29473670431 @default.
• W2947367043 hasLocation W29473670432 @default.
• W2947367043 hasLocation W29473670433 @default.
• W2947367043 hasLocation W29473670434 @default.

• next